1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2.
Research Methodology
2.1.
Objective of the Study
2.2.
Baseline Methodology
2.3.
Key Industry Partners
2.4.
Major Association and Secondary Sources
2.5.
Forecasting Methodology
2.6.
Data Triangulation & Validations
2.7.
Assumptions and Limitations
3.
Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4.
Voice of Customer
5. Global Drug Screening Market Outlook
5.1.
Market Size &
Forecast
5.1.1. By Value
5.2.
Market Share &
Forecast
5.2.1. By Product
& Services (Drug Screening Product, Analytical Instruments, Rapid Testing
Devices, Oral Fluid Testing Devices, Consumables, Drug Screening Service)
5.2.2. By Sample
Type (Urine Samples, Breath Samples, Oral Fluid Samples, Hair Samples, Other
Samples)
5.2.3.
By End User (Drug Testing Laboratories, Workplaces, Criminal
Justice and Law Enforcement Agencies, Hospitals, Drug Treatment Centers, Individual
Users, Pain Management Centers, Schools and Colleges)
5.2.4.
By Region
5.2.5.
By Company (2023)
5.3.
Market Map
5.3.1.
By Product & Services
5.3.2.
By Sample Type
5.3.3.
By End User
5.3.4. By Region
6. North America Drug Screening
Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Product
& Services
6.2.2.
By Sample Type
6.2.3. By End
User
6.2.4.
By Country
6.2.4.1.
United States Drug
Screening Market Outlook
6.2.4.1.1.
Market Size &
Forecast
6.2.4.1.1.1.
By Value
6.2.4.1.2.
Market Share &
Forecast
6.2.4.1.2.1.
By Product & Services
6.2.4.1.2.2.
By Sample Type
6.2.4.1.2.3.
By End User
6.2.4.2.
Canada Drug
Screening Market Outlook
6.2.4.2.1.
Market Size &
Forecast
6.2.4.2.1.1.
By Value
6.2.4.2.2.
Market Share &
Forecast
6.2.4.2.2.1.
By Product & Services
6.2.4.2.2.2.
By Sample Type
6.2.4.2.2.3.
By End User
6.2.4.3.
Mexico Drug
Screening Market Outlook
6.2.4.3.1.
Market Size &
Forecast
6.2.4.3.1.1.
By Value
6.2.4.3.2.
Market Share &
Forecast
6.2.4.3.2.1.
By Product & Services
6.2.4.3.2.2.
By Sample Type
6.2.4.3.2.3.
By End User
7. Europe Drug Screening Market Outlook
7.1. Market Size & Forecast
7.1.1. By Value
7.2. Market Share & Forecast
7.2.1.
By Product & Services
7.2.2.
By Sample Type
7.2.3.
By End User
7.2.4.
By Country
7.2.4.1.
France Drug
Screening Market Outlook
7.2.4.1.1.
Market Size &
Forecast
7.2.4.1.1.1.
By Value
7.2.4.1.2.
Market Share &
Forecast
7.2.4.1.2.1.
By Product & Services
7.2.4.1.2.2.
By Sample Type
7.2.4.1.2.3.
By End User
7.2.4.2.
Germany Drug
Screening Market Outlook
7.2.4.2.1.
Market Size &
Forecast
7.2.4.2.1.1.
By Value
7.2.4.2.2.
Market Share &
Forecast
7.2.4.2.2.1.
By Product & Services
7.2.4.2.2.2.
By Sample Type
7.2.4.2.2.3.
By End User
7.2.4.3.
United Kingdom Drug Screening
Market Outlook
7.2.4.3.1.
Market Size &
Forecast
7.2.4.3.1.1.
By Value
7.2.4.3.2.
Market Share &
Forecast
7.2.4.3.2.1.
By Product & Services
7.2.4.3.2.2.
By Sample Type
7.2.4.3.2.3.
By End User
7.2.4.4.
Italy Drug Screening
Market Outlook
7.2.4.4.1.
Market Size &
Forecast
7.2.4.4.1.1.
By Value
7.2.4.4.2.
Market Share &
Forecast
7.2.4.4.2.1.
By Product & Services
7.2.4.4.2.2.
By Sample Type
7.2.4.4.2.3.
By End User
7.2.4.5.
Spain Drug Screening
Market Outlook
7.2.4.5.1.
Market Size &
Forecast
7.2.4.5.1.1.
By Value
7.2.4.5.2.
Market Share &
Forecast
7.2.4.5.2.1.
By Product & Services
7.2.4.5.2.2.
By Sample Type
7.2.4.5.2.3.
By End User
8. Asia Pacific Drug Screening
Market Outlook
8.1. Market Size & Forecast
8.1.1. By Value
8.2. Market Share & Forecast
8.2.1.
By Product & Services
8.2.2.
By Sample Type
8.2.3.
By End User
8.2.4.
By Country
8.2.4.1.
China Drug Screening
Market Outlook
8.2.4.1.1.
Market Size &
Forecast
8.2.4.1.1.1.
By Value
8.2.4.1.2.
Market Share &
Forecast
8.2.4.1.2.1.
By Product & Services
8.2.4.1.2.2.
By Sample Type
8.2.4.1.2.3.
By End User
8.2.4.2.
India Drug Screening
Market Outlook
8.2.4.2.1.
Market Size &
Forecast
8.2.4.2.1.1.
By Value
8.2.4.2.2.
Market Share &
Forecast
8.2.4.2.2.1.
By Product & Services
8.2.4.2.2.2.
By Sample Type
8.2.4.2.2.3.
By End User
8.2.4.3.
South Korea Drug
Screening Market Outlook
8.2.4.3.1.
Market Size &
Forecast
8.2.4.3.1.1.
By Value
8.2.4.3.2.
Market Share &
Forecast
8.2.4.3.2.1.
By Product & Services
8.2.4.3.2.2.
By Sample Type
8.2.4.3.2.3.
By End User
8.2.4.4.
Japan Drug Screening
Market Outlook
8.2.4.4.1.
Market Size &
Forecast
8.2.4.4.1.1.
By Value
8.2.4.4.2.
Market Share &
Forecast
8.2.4.4.2.1.
By Product & Services
8.2.4.4.2.2.
By Sample Type
8.2.4.4.2.3.
By End User
8.2.4.5.
Australia Drug
Screening Market Outlook
8.2.4.5.1.
Market Size &
Forecast
8.2.4.5.1.1.
By Value
8.2.4.5.2.
Market Share &
Forecast
8.2.4.5.2.1.
By Product & Services
8.2.4.5.2.2.
By Sample Type
8.2.4.5.2.3.
By End User
9. South America Drug Screening
Market Outlook
9.1. Market Size & Forecast
9.1.1. By Value
9.2. Market Share & Forecast
9.2.1.
By Product & Services
9.2.2.
By Sample Type
9.2.3.
By End User
9.2.4.
By Country
9.2.4.1.
Brazil Drug Screening
Market Outlook
9.2.4.1.1.
Market Size &
Forecast
9.2.4.1.1.1.
By Value
9.2.4.1.2.
Market Share &
Forecast
9.2.4.1.2.1.
By Product & Services
9.2.4.1.2.2.
By Sample Type
9.2.4.1.2.3.
By End User
9.2.4.2.
Argentina Drug
Screening Market Outlook
9.2.4.2.1.
Market Size &
Forecast
9.2.4.2.1.1.
By Value
9.2.4.2.2.
Market Share &
Forecast
9.2.4.2.2.1.
By Product & Services
9.2.4.2.2.2.
By Sample Type
9.2.4.2.2.3.
By End User
9.2.4.3.
Colombia Drug
Screening Market Outlook
9.2.4.3.1.
Market Size &
Forecast
9.2.4.3.1.1.
By Value
9.2.4.3.2.
Market Share &
Forecast
9.2.4.3.2.1.
By Product & Services
9.2.4.3.2.2.
By Sample Type
9.2.4.3.2.3.
By End User
10. Middle East & Africa Drug Screening
Market Outlook
10.1.
Market Size &
Forecast
10.1.1. By Value
10.2.
Market Share &
Forecast
10.2.1.
By Product & Services
10.2.2.
By Sample Type
10.2.3.
By End User
10.2.4.
By Country
10.2.4.1. South Africa Drug Screening
Market Outlook
10.2.4.1.1.
Market Size &
Forecast
10.2.4.1.1.1.
By Value
10.2.4.1.2.
Market Share &
Forecast
10.2.4.1.2.1.
By Product & Services
10.2.4.1.2.2.
By Sample Type
10.2.4.1.2.3.
By End User
10.2.4.2. Saudi Arabia Drug Screening
Market Outlook
10.2.4.2.1.
Market Size &
Forecast
10.2.4.2.1.1.
By Value
10.2.4.2.2.
Market Share &
Forecast
10.2.4.2.2.1.
By Product & Services
10.2.4.2.2.2.
By Sample Type
10.2.4.2.2.3.
By End User
10.2.4.3. UAE Drug Screening Market Outlook
10.2.4.3.1.
Market Size &
Forecast
10.2.4.3.1.1.
By Value
10.2.4.3.2.
Market Share &
Forecast
10.2.4.3.2.1.
By Product & Services
10.2.4.3.2.2.
By Sample Type
10.2.4.3.2.3.
By End User
11.
Market Dynamics
11.1.
Drivers
11.2.
Challenges
12.
Market Trends &
Developments
12.1.
Recent Development
12.2.
Mergers &
Acquisitions
12.3.
Product Launches
13.
Competitive
Landscape
13.1. Quest Diagnostics Inc.
13.1.1. Business Overview
13.1.2. Company Snapshot
13.1.3. Products & Services
13.1.4. Financials ( as reported)
13.1.5. Recent Developments
13.1.4. Key Personnel Details
13.1.5. SWOT Analysis
13.2. Heska Corporation
13.3. Thermo Fisher Scientific, Inc.
13.4. Alfa Scientific Designs, Inc.
13.5. OraSure Technologies, Inc.
13.6. F. Hoffmann-La Roche Ltd
13.7. MPD Inc.
13.8. Shimadzu Corporation
13.9.Lifeloc Technologies, Inc.
13.10.Drägerwerk AG & Co. KGaA
13.11.Premier Biotech, Inc.
13.12.Omega Laboratories, Inc.
14. Strategic
Recommendations
15. About us
& Disclaimer